Extended Management and Measurement of Autism
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2010-02-23
- Lead Sponsor
- Neuropharm
- Target Recruit Count
- 128
- Registration Number
- NCT00787111
- Locations
- ๐บ๐ธ
Southwest Autism Research and Resource Centre, Phoenix, Arizona, United States
๐บ๐ธUniversity of North Carolina, Chapel Hill, North Carolina, United States
๐บ๐ธCRCNJ, Voorhees, New Jersey, United States
Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
Phase 1
Completed
- Conditions
- Fragile X Syndrome
- First Posted Date
- 2008-03-17
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Neuropharm
- Target Recruit Count
- 12
- Registration Number
- NCT00637221
- Locations
- ๐บ๐ธ
Rush University Medical Centre, Chicago, Illinois, United States
๐บ๐ธMIND Institute, Sacramento, California, United States
Study of Fluoxetine in Autism
- First Posted Date
- 2007-08-13
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Neuropharm
- Target Recruit Count
- 158
- Registration Number
- NCT00515320
- Locations
- ๐บ๐ธ
Center for Psychiatry and Behavioral Medicine, Las Vegas, Nevada, United States
๐บ๐ธUniversity of California Davis, Sacramento, California, United States
๐บ๐ธUniversity of Florida, Department of Psychiatry, Gainesville, Florida, United States
Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
Phase 2
Terminated
- Conditions
- Obsessive Compulsive Disorder
- First Posted Date
- 2007-08-13
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Neuropharm
- Target Recruit Count
- 6
- Registration Number
- NCT00515255
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, Columbia University, New York, New York, United States
๐บ๐ธUniversity Hospitals Case Medical Center, Cleveland, Ohio, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath